Nubeqa® (darolutamide)
for Prostate Cancer

Nubeqa (darolutamide) is a prescription medicine used to treat prostate cancer. It is prescribed for non-metastatic castration-resistant prostate cancer (nmCRPC), where the cancer no longer responds to treatments lowering testosterone. Nubeqa also treats metastatic hormone-sensitive prostate cancer (mHSPC) in combination with docetaxel. It works by blocking androgens, hormones that help prostate cancer cells grow, slowing cancer progression.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Prostate Cancer